Celularity (CELUW) Research & Development (2020 - 2025)
Celularity (CELUW) reported Research & Development of $3.3 million for Q4 2025, down 12.57% year-over-year from $3.8 million in Q4 2024, and down 27.21% quarter-over-quarter from $4.6 million in Q3 2025.
Celularity (CELUW) Research & Development (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Research & Development data on file, last reported at $3.3 million in Q4 2025.
- Research & Development for Q4 2025 came in at $3.3 million, down 12.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.0 million (down 13.58% YoY), and the FY2025 annual result was $15.0 million, down 13.58% from the prior year.
- Research & Development fell to $3.3 million in Q4 2025 per CELUW's latest filing, from $4.6 million in the prior quarter.
- Over five years, Research & Development peaked at $25.3 million in Q2 2022 and troughed at -$272000.0 in Q4 2023.
- A 5-year average of $11.5 million and a median of $7.2 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2024: Research & Development sank 102.47% in 2023, then surged 1507.35% in 2024.
- A 5-year view of Research & Development shows it stood at $24.7 million in 2021, then plunged by 55.48% to $11.0 million in 2022, then plunged by 102.47% to -$272000.0 in 2023, then surged by 1507.35% to $3.8 million in 2024, then dropped by 12.57% to $3.3 million in 2025.
- Business Quant data shows CELUW's Research & Development at $3.3 million in Q4 2025, $4.6 million in Q3 2025, and $3.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | 5.18 Mn |
| Jun 30, 2023 | 8.60 Mn |
| Mar 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 10.99 Mn |
| Sep 30, 2022 | 20.35 Mn |
| Jun 30, 2022 | 25.35 Mn |
| Mar 31, 2022 | 21.67 Mn |
| Dec 31, 2021 | 24.69 Mn |
| Sep 30, 2021 | 23.77 Mn |
| Jun 30, 2021 | 22.91 Mn |
| Mar 31, 2021 | 16.99 Mn |